Please assess the completion status of the following clinical trial:

Trial Title: Nitrofurantoin and Urinary Tract Infections (UTIs)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women who fail a post-operative voiding trial and are willing to learn clean intermittent self-catheterization (CISC) prior to discharge from the hospital~Exclusion Criteria:~* Known drug allergy to nitrofurantoin~* A history of renal insufficiency~* Renal transplant~* Renal nephropathy~* A recent history of more than 3 Urinary Tract Infections (UTIs) per year~* Known immunocompromised condition (organ transplant, chemotherapy for cancer or arthritis, autoimmune diseases (lupus etc)).

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Arm 1: Nitrofurantoin Group (Type: EXPERIMENTAL): extended release nitrofurantoin 100mg to be taken daily while performing clean intermittent self-catheterization (CISC) and for three more days after stopping CISC
- Arm 2: Placebo Group (Type: PLACEBO_COMPARATOR): identical appearing placebo capsule to be taken daily while performing clean intermittent self-catheterization (CISC) and for three more days after stopping CISC

Based on this trial design, predict the completion outcome and termination type (if applicable).